Stratos Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Buy |
3,928
+832
| +27% | +$57.4K | 0.01% | 566 |
|
|
2025
Q1 | $215K | Sell |
3,096
-2,755
| -47% | -$191K | 0.01% | 615 |
|
|
2024
Q4 | $503K | Sell |
5,851
-4,216
| -42% | -$363K | 0.02% | 473 |
|
|
2024
Q3 | $1.2M | Sell |
10,067
-1,115
| -10% | -$133K | 0.06% | 321 |
|
|
2024
Q2 | $1.6M | Sell |
11,182
-581
| -5% | -$82.9K | 0.08% | 245 |
|
|
2024
Q1 | $1.51M | Buy |
11,763
+5,777
| +97% | +$742K | 0.09% | 241 |
|
|
2023
Q4 | $619K | Buy |
5,986
+3,383
| +130% | +$350K | 0.04% | 423 |
|
|
2023
Q3 | $237K | Buy |
+2,603
| New | +$237K | 0.02% | 585 |
|
|
2022
Q3 | – | Sell |
-3,582
| Closed | -$200K | – | 522 |
|
|
2022
Q2 | $200K | Buy |
+3,582
| New | +$200K | 0.02% | 496 |
|